CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans

被引:139
作者
Taborda, CP
Casadevall, A [1 ]
机构
[1] Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
关键词
D O I
10.1016/S1074-7613(02)00328-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IgM and IgA to the Cryptococcus neoformans capsular glucuronoxylomannan (GXM) promote complement-independent phagocytosis by macrophages with efficiency comparable to that of IgG1. IgM- and IgA-mediated phagocytosis of C. neoformans was proportional to CR3 expression, inhibited by Abs to CR3 (CD11b/ CD18) and CR4 (CD11c/CD18), and dramatically reduced with macrophages of CD18-deficient mice. IgM and IgA promoted ingestion of yeast cells by CHO cells expressing CR3 and CR4. In contrast, IgG1-mediated phagocytosis was only partially inhibited by Abs to CR3 and CR4. Phagocytosis by IgM and IgA but not IgG1 was inhibited by soluble GXM,which binds CD18. Involvement of CR in antibody-mediated complement-independent phagocytosis indicates a new link between innate and adaptive immune systems.
引用
收藏
页码:791 / 802
页数:12
相关论文
共 43 条
[1]   STUDIES OF MACROPHAGE COMPLEMENT RECEPTOR - ALTERATION OF RECEPTOR FUNCTION UPON MACROPHAGE ACTIVATION [J].
BIANCO, C ;
GRIFFIN, FM ;
SILVERSTEIN, SC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 141 (06) :1278-1290
[2]   ANTIBODIES ELICITED BY A CRYPTOCOCCUS-NEOFORMANS TETANUS TOXOID CONJUGATE VACCINE HAVE THE SAME SPECIFICITY AS THOSE ELICITED IN INFECTION [J].
CASADEVALL, A ;
MUKHERJEE, J ;
DEVI, SJN ;
SCHNEERSON, R ;
ROBBINS, JB ;
SCHARFF, MD .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (06) :1086-1093
[3]  
Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, DOI DOI 10.1128/9781555818241
[4]   A GALACTOXYLOMANNAN ANTIGEN OF CRYPTOCOCCUS-NEOFORMANS SEROTYPE-A [J].
CHERNIAK, R ;
REISS, E ;
TURNER, SH .
CARBOHYDRATE RESEARCH, 1982, 103 (02) :239-250
[5]   Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release [J].
Cleare, W ;
Casadevall, A .
MEDICAL MYCOLOGY, 1999, 37 (04) :235-243
[6]   The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays [J].
Cleare, W ;
Casadevall, A .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (02) :125-129
[7]  
CZOP JK, 1985, J IMMUNOL, V135, P3388
[8]  
DESHAW M, 1995, CLIN EXP IMMUNOL, V99, P425, DOI 10.1111/j.1365-2249.1995.tb05568.x
[9]   Molecular characterization of a cDNA that encodes six isoforms of a novel murine A kinase anchor protein [J].
Dong, F ;
Feldmesser, M ;
Casadevall, A ;
Rubin, CS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (11) :6533-6541
[10]   Cryptococcal polysaccharides bind to CD18 on human neutrophils [J].
Dong, ZM ;
Murphy, JW .
INFECTION AND IMMUNITY, 1997, 65 (02) :557-563